MAZ-mediated tumor progression and immune evasion in hormone receptor-positive breast cancer: Targeting tumor microenvironment and PCLAF+ subtype-specific therapy.

Transl Oncol · 2025 · PMC11780959 · PMID 39805182

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

For further differentiation, p -values less than 0.01 were categorized as very significant, p -values less than 0.001 as highly significant, and those below 0.0001 as extremely significant.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.